InsiderFlow

Kevin Joseph Fitzgerald

ALNY

Kevin Joseph Fitzgerald serves as officer: CSO & EVP, Head of Research at Alnylam Pharmaceuticals, Inc. (ALNY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

15 trades

$23.40M

Net Position

Net Seller

$23.40M

Companies Traded

1

ALNY

Active Period

Jun 2024 – Mar 2026

15 total trades

Most Recent

Sell ALNY

Mar 6, 2026 · $417.7K

Kevin Joseph Fitzgerald's Insider Trading at Alnylam Pharmaceuticals, Inc. (ALNY)

Buys

0 · $0.00

Sells

15 · $23.40M

Total Shares Bought

0

Total Shares Sold

70,873

ALNY Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Mar 6, 2026Sell1,291$323.54$417.7K21,831
Mar 4, 2026Sell6,500$323.62$2.10M25,063
Feb 17, 2026Sell4,000$321.25$1.28M23,305
Feb 12, 2026Sell4,000$321.25$1.28M0
Jan 14, 2026Sell3,740$367.35$1.37M25,025
Jan 11, 2026Sell3,800$367.37$1.40M0
Nov 17, 2025Sell12,128$452.18$5.48M0
Oct 1, 2025Sell2,441$452.05$1.10M0
Aug 15, 2025Sell1,396$453.27$632.8K0
Mar 3, 2025Sell2,755$242.94$669.3K0
Feb 28, 2025Sell496$241.69$119.9K0
Feb 13, 2025Sell2,103$252.71$531.4K0
Nov 25, 2024Sell3,000$251.65$754.9K0
Aug 12, 2024Sell22,025$270.99$5.97M0
Jun 24, 2024Sell1,198$230.99$276.7K0